CARY, N.C., Jan. 28, 2025 /PRNewswire/ — InstantGMP™, a leader in fully integrated GMP-compliant software solutions for pharmaceutical manufacturing, proudly announces its new partnership with Corsair Pharma, an innovative biopharmaceutical company focused on enhancing the effectiveness of medications to create improved treatment options for patients with complex medical needs.
Corsair Pharma is revolutionizing pulmonary arterial hypertension (PAH) treatment with its first product candidate: a prodrug of treprostinil delivered via a proprietary transdermal patch.
As they prepare for Phase One clinical trials, Corsair Pharma is prioritizing safety, tolerability, and quality at every stage of development. To support these critical goals, the company has transitioned from a paper-based system to InstantGMP’s Quality Management System (QMS) and Document Management System (DMS) modules.
With InstantGMP’s Quality Management System, Corsair Pharma benefits from:
- Detailed Quality Assurance:Rigorous quality standards ensure …